Schnall R, Michaels CL, Sánchez E, Alexander A, Jimenez J, Halpern M, Brin M, Ozoria Ramírez S, Stonbraker S, Báez Caraballo P. Usability and Satisfaction with the WiseApp and CleverCap: A Culturally Adapted mHealth Intervention for Spanish-Speaking People Living with HIV in the Dominican Republic and New York City. Stud Health Technol Inform. 2026 May 21; 336:1945-1946.

Iriarte E, Hawkins KL, Wilson MP, Webel AR, Oliveira VH, Khuu V, Kulik GL, Cook P, Ghosh D, Jankowski C, Erlandson KM. The Impact of Social Vulnerability on Exercise Outcomes: A Longitudinal Study of Physical Function in Older People With HIV. J Int Assoc Provid AIDS Care. 2026 Jan-Dec; 25:23259582261448699.

Valentin OR, Henderson C, Coffin LS, Paredes-Gotamco J, Olem D, Farrales W, Neilands TB, Dilworth SE, Doblecki-Lewis S, Page K, Moskowitz JT, Anderson PL, Johnson MO, Carrico AW. Positive psychological intervention to reduce HIV acquisition risk with men who use stimulants: protocol for a randomised controlled trial. BMJ Open. 2026 May 11; 16(5):e120232.

Khaitan A, Lindsey JC, Capparelli EV, Tierney C, Coletti A, Perlowski C, Yin DE, Smith MEB, Spiegel HML, Majji S, Moye J, Gama L, Koup RA, Lin BC, McDermott AB, Purdue L, Krotje C, Harding PA, Cotton MF, Costello D, Petropoulos CJ, Reeves JD, Mallewa M, Chihana R, Kamthunzi P, Mbengeranwa TG, Masheto G, Santos Cruz ML, Pilotto JH, Ponatshego PL, Persaud D, McFarland EJ. VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines. Sci Transl Med. 2026 May 06; 18(848):eadr4509.

Colasanti JA, Aldredge A, Niles-Carnes LV, Ochieng E, Pareek P, Robinson V, Anderson E, Castaneda M, Spralling H, Smith BL, Sumitani J, Paul Leue E, Moran CA, Lora M, Armstrong WS, Collins LF. Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. Clin Infect Dis. 2026 Apr 30; 82(4):564-574.

Beck IA, Boyce CL, Bishop MD, Oldroyd AR, du Toit L, Saimen A, Ramarope KM, Hitchcock S, du Plessis NM, Mbogo L, Chohan BH, Maheria P, Oyaro P, Knowles K, Zhang Z, Brummel SS, Drain PK, Smith RA, Gottlieb GS, Abuogi L, Patel RC, Farquhar C, Wiznia A, Ruel TD, Rossouw TM, Hawes SE, Frenkel LM. HIV Resistance to Dolutegravir Varies With Coadministered Agents. Clin Infect Dis. 2026 Apr 30; 82(4):592-596.

Mann SC, Lykins D, Coyle RP, Witt MD, Kim EY, Macatangay B, Brown TT, Dionne JA, Alcaide M, Lahiri CD, Ramirez C, Dumond JB, D'Souza G, Cohen MH, Wilson TE, Kassaye S, Tien PC, Adedimeji AA, Ellison L, Brooks KM, Bushman LR, Anderson PL, MaWhinney S. In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort. Clin Infect Dis. 2026 Apr 30; 82(4):575-582.

Hossain F, Sharfaraz A, Ghosh P, Sarwar G, Uddin MR, Rashid MU, Ghosh D, Nath R, Maruf S, Sagar SK, Shomik MS, Nath P, Sohel ANM, Hossain MS, Khan SI, Banjara MR, Halleux CM, Aseffa A, Mondal D. Visceral leishmaniasis & HIV co-infection in Bangladesh: Investigating prevalence and policy recommendations. J Infect Public Health. 2026 Jun; 19(6):103233.

Mpofu R, Chandiwana N, Sokhela S, Moorhouse M, Venter F, Anderson PL, Wiesner L, Boffito M, Maartens G, Sinxadi P. The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis. J Acquir Immune Defic Syndr. 2026 Apr 01; 101(4):424-431.

Hwang YJ, Lesko CR, Brown TT, Alexander GC, Althoff KN, Zalla LC, Pytell JD, Falade-Nwulia O, Tseng E, Moore RD, Marconi VC, Koethe JR, Silverberg MJ, Horberg MA, Lang R, Sterling TR, Fojo AT. Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. Lancet HIV. 2026 May; 13(5):e297-e305.